Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones
- 1 September 2013
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 42 (3) , 232-237
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K24 AI65298, R01 AI063200, T32 AI07474-16)
- National Institute of Allergy and Infectious Diseases
This publication has 29 references indexed in Scilit:
- WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 updateEuropean Respiratory Journal, 2011
- Fluoroquinolone Resistance in Mycobacterium tuberculosis : The Effect of Duration and Timing of Fluoroquinolone ExposureAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Empirical Treatment of Community‐Acquired Pneumonia and the Development of Fluoroquinolone‐Resistant TuberculosisClinical Infectious Diseases, 2009
- Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trialThe Lancet, 2009
- Increasing Outpatient Fluoroquinolone Exposure Before Tuberculosis Diagnosis and Impact on Culture-Negative DiseaseArchives of internal medicine (1960), 2007
- The Quinolones: Past, Present, and FutureClinical Infectious Diseases, 2005
- The newer fluoroquinolonesInfectious Disease Clinics of North America, 2004
- Fluoroquinolones, tuberculosis, and resistanceThe Lancet Infectious Diseases, 2003
- Sterilizing Activities of Fluoroquinolones against Rifampin-Tolerant Populations of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2003
- Expanded activity and utility of the new fluoroquinolones: A reviewClinical Therapeutics, 1999